// App-Quantinova.ai

2148 : Insulin secretion and decreased glucose clearance are associated with enhanced fibrogen‐ esis and a high risk of disease progression in non‐diabetic patients with Non Alcoholic Fatty Liver Disease

Researchers

Presenter

  • Ramy Younes

Principal Investigators

  • Chiara Rosso

  • Melania Gaggini

  • Lavinia Mezzabotta

  • Milena Marietti

  • Fabrizia Carli

  • Federico Salomone

  • Emma Buzzigoli

  • Gian Paolo Caviglia

  • Chiara Barbieri

  • Maria Lorena Abate

  • Antonina Smedile

  • Giorgio Maria Saracco

  • Quentin M. Anstee

  • Diana J. Leeming

  • Amalia Gastaldelli

  • Detlef Schuppan

  • Elisabetta Bugianesi

Medical Centers

  • Department of Health Sciences, Univeristy of Milan, Milan, Italy

  • CNR, Institute of Clinical Physiology, Pisa, Italy

  • Division of Gastroenterology, Ospedale Acireale, Catania, Italy

  • Newcastle University, Newcastle upon Tyne, United Kingdom

  • Biomarkers and Research, Nordic Bioscience, Herlev, Denmark,

  • Translational Immunology, University Medical Center, Mainz, Germany

Locations

  • Italy

  • United Kingdom

  • Denmark

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Fatty Liver Disease

  • Nonalcoholic fatty liver disease

  • Fontaine progeroid syndrome

Biomarkers

  • Insulin

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved